Yanli Wu

Prof. Dr. Yanli Wu


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 February 2025 in Ultrasonics Sonochemistry
Verified
Journal Article
Open access
JGJing Guan
Jing Guan
PGPeng Guo
Peng Guo
MCMeng Chen
Meng Chen
WWWenzhao Wang
Wenzhao Wang
XCXinyu Chen
Xinyu Chen
YWYanli Wu
Yanli Wu
Perilla leaves are a common traditional medicinal and edible crop, in order to further explore its medicinal value, after determining the optimal ultrasound-assisted extraction conditions a neutral polysaccharide was extracted. Its structure was analyzed, and sulfation modification was carried out. After purification by different column chromatography, the optimal process for sulfation modification of PLP-2-1 was established, and sulfated modified PLP-2-1 (S-PLP-2-1) was successfully prepared. The potential structural framework and molecular weight of PLP-2-1 were determined by high performance liquid chromatography (HPLC), methylation analysis, and nuclear magnetic resonance (NMR) techniques, while sulfated modified S-PLP-2-1 maintained a high degree of structural similarity to PLP-2-1. Particle size analysis, Zeta potential measurement, infrared spectroscopy, and NMR analysis confirmed the presence of sulfate groups in S-PLP-2-1, while thermogravimetric and rheological analyses provided support for the development and utilization of these two polysaccharides. After determined the safe concentration range in vitro, the antioxidant and hypoglycemic activities of PLP-2-1 and S-PLP-2-1 were measured. Besides, the effects on the levels of total cholesterol (TC), triglyceride (TG), high-density lipoprotein cholesterol (HDL-C), and low-density lipoprotein cholesterol (LDL-C) in oleic acid (OA) induced high-fat HepG2 cells of both polysaccharides were determined. The results indicated that the various biological activities of S-PLP-2-1 were significantly enhanced after sulfation modification. Therefore, PLP-2-1 and S-PLP-2-1 have the potential to be developed as drugs for anti-glycolipid metabolism disorders.

12 April 2024 in Molecules
Verified
Journal Article
Open access
PDF file
PGPeng Guo
Peng Guo
MCMeng Chen
Meng Chen
WWWenzhao Wang
Wenzhao Wang
QLQiuyun Li
Qiuyun Li
XCXinyu Chen
Xinyu Chen
YWYanli Wu
Yanli Wu
Phyllanthus emblica is a natural medicinal herb with diverse bioactivities. Certain extracts from this herb have been confirmed to possess anti-glycolipid metabolic disorder activity. To further develop its utility value and explore its potential in combating glycolipid metabolic disorders, we designed a series of experiments to investigate the structure, antioxidant activity, and anti-glycolipid metabolic disorder activity of Phyllanthus emblica polysaccharides. In this study, we extracted and purified polysaccharides from Phyllanthus emblica and thoroughly analyzed their structure using various techniques, including NMR, methylation analysis, and surface-enhanced Raman spectroscopy. We investigated the hypolipidemic and anti-glycolipid metabolism disorder activity of Phyllanthus emblica polysaccharides for the first time utilizing oleic acid (OA) and advanced glycation end products (AGEs) as inducers. Additionally, the antioxidant activity of Phyllanthus emblica polysaccharides was assessed in vitro. These findings lay the groundwork for future investigations into the potential application of Phyllanthus emblica polysaccharides as an intervention for preventing and treating diabetes.

16 February 2026 in Ultrasonics Sonochemistry
Verified
Journal Article
Open access
PGPeng Guo
Peng Guo
JLJiayue Liang
Jiayue Liang
YHYiyang He
Yiyang He
YXYaowen Xing
Yaowen Xing
XQXubin Quan
Xubin Quan
YWYanli Wu
Yanli Wu
Dryopteridis crassirhizomatis Rhizoma, the traditional Chinese medicinal herb commonly known as "Mianma Guanzhong", botanically originating from the dried rhizome of Dryopteris crassirhizoma Nakai, exhibits extensive pharmacological activities. To further elaborate on its medicinal potential, a homogeneous polysaccharide, designated as DCP-1-2, was ultrasonic-assisted extracted and purified from the dried rhizomes of Dryopteris crassirhizoma. Subsequently, comprehensive structural elucidation of DCP-1-2 was conducted using a combination of advanced analytical techniques, including HPLC, SERS, methylation analysis, and NMR spectroscopy. Notably, systematic in vitro assessments were performed to evaluate two key biological activities of DCP-1-2: its antioxidant capacity and its inhibitory effects on key enzymes implicated in glucose and lipid metabolism. To this end, as a critical crosslink between glucose and lipid metabolic pathways, AGEs were employed to establish a high-fat cell model. This cell model was then utilized to investigate the anti-GLMD activity of DCP-1-2 and to decipher the underlying molecular mechanisms. Collectively, these findings lay a solid experimental foundation for the potential application of Dryopteris crassirhizoma-derived polysaccharides in the prevention and management of GLMD.